Literature DB >> 15347567

Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction.

R Duncan Hite1, Michael C Seeds, David L Bowton, Bonnie L Grier, Anca M Safta, Rajesh Balkrishnan, B Moseley Waite, David A Bass.   

Abstract

In asthma, inflammation-mediated surfactant dysfunction contributes to increased airway resistance, but the mechanisms for dysfunction are not understood. To test mechanisms that alter surfactant function, atopic asthmatics underwent endobronchial antigen challenge and bronchoalveolar lavage (BAL). BAL fluids were sequentially separated into cells, surfactant, and supernatant, and multiple end points were analyzed. Each end point's unique relationship to surfactant dysfunction was determined. Our results demonstrate that minimum surface tension (gamma(min)) of surfactant after antigen challenge was significantly increased with a spectrum of responses that included dysfunction in 6 of 13 asthmatics. Antigen challenge significantly altered the partitioning of surfactant phospholipid measured as a decreased ratio of large surfactant aggregates (LA) to small surfactant aggregates (SA), LA/SA ratio. Phosphatidylglycerol (PG) was significantly reduced in the LA of the dysfunctional asthmatic BALs. There was a corresponding significant increase in the ratio of phosphatidylcholine to PG, which strongly correlated with both increased gamma(min) and decreased LA/SA. Altered surfactant phospholipid properties correlated with surfactant dysfunction as well or better than either increased eosinophils or protein. Secretory phospholipase activity, measured in vitro, increased after antigen challenge and may explain the decrease in surfactant PG. In summary, alteration of phospholipids, particularly depletion of PG, in the LA of surfactant may be an important mechanism in asthma-associated surfactant dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15347567     DOI: 10.1152/ajplung.00273.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  10 in total

1.  Pseudomonas aeruginosa and sPLA2 IB stimulate ABCA1-mediated phospholipid efflux via ERK-activation of PPARalpha-RXR.

Authors:  Marianna Agassandian; Olga L Miakotina; Matthew Andrews; Satya N Mathur; Rama K Mallampalli
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

Review 2.  Therapeutic use of surfactant components in allergic asthma.

Authors:  Veit J Erpenbeck; Norbert Krug; Jens M Hohlfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

3.  Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.

Authors:  Koji Kuronuma; Hiroaki Mitsuzawa; Katsuyuki Takeda; Chiaki Nishitani; Edward D Chan; Yoshio Kuroki; Mari Nakamura; Dennis R Voelker
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

4.  Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.

Authors:  R Duncan Hite; Bonnie L Grier; B Moseley Waite; Ruud A Veldhuizen; Fred Possmayer; Li-Juan Yao; Michael C Seeds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-28       Impact factor: 5.464

5.  Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C.

Authors:  Karina Rodríguez-Capote; Dahis Manzanares; Thomas Haines; Fred Possmayer
Journal:  Biophys J       Date:  2006-01-27       Impact factor: 4.033

6.  Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome.

Authors:  Michael C Seeds; Bonnie L Grier; Bruce N Suckling; Anca M Safta; David L Long; B Moseley Waite; Peter E Morris; R Duncan Hite
Journal:  Am J Med Sci       Date:  2012-06       Impact factor: 2.378

7.  Site of allergic airway narrowing and the influence of exogenous surfactant in the Brown Norway rat.

Authors:  Sana Siddiqui; Kimitake Tsuchiya; Paul-André Risse; Sharon R Bullimore; Andrea Benedetti; James G Martin
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

Review 8.  Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.

Authors:  Mari Numata; Dennis R Voelker
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-02-28       Impact factor: 5.228

9.  Lung Surfactant Lipids Provide Immune Protection Against Haemophilus influenzae Respiratory Infection.

Authors:  Belén García-Fojeda; Zoe González-Carnicero; Alba de Lorenzo; Carlos M Minutti; Lidia de Tapia; Begoña Euba; Alba Iglesias-Ceacero; Sonia Castillo-Lluva; Junkal Garmendia; Cristina Casals
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

10.  Three Alveolar Phenotypes Govern Lung Function in Murine Ventilator-Induced Lung Injury.

Authors:  Bradford J Smith; Gregory S Roy; Alyx Cleveland; Courtney Mattson; Kayo Okamura; Chantel M Charlebois; Katharine L Hamlington; Michael V Novotny; Lars Knudsen; Matthias Ochs; R Duncan Hite; Jason H T Bates
Journal:  Front Physiol       Date:  2020-06-30       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.